Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
The Most Dysfunctional Leadership Habit In Healthcare: ‘Split The Baby’ Thinking
The article warns that healthcare leaders often default to “split the baby” thinking—seeking compromise instead of decisive, evidence‑based choices. This habit turns complex, high‑stakes decisions into watered‑down middle grounds, leaving initiatives half‑implemented and outcomes stagnant. The author argues that true leadership requires principled judgment, open debate, and the willingness to make uncomfortable calls. In an era of rising costs, workforce strain, and regulatory pressure, organizations that avoid neutrality and act decisively will outperform those stuck in perpetual compromise.
Judge Lets State Auditor’s Investigation Into Data Breach Affecting Blue Cross Blue Shield Members Move Forward
A Montana state district judge dismissed Health Care Service Corporation’s lawsuit, allowing the state auditor to continue probing a data breach that may have exposed the protected health information of roughly 462,000 Blue Cross Blue Shield of Montana members. The...
What Symptoms of a Traumatic Brain Injury Appear After Impact
A traumatic brain injury (TBI) may produce symptoms immediately or only after hours or days, making early vigilance essential. Early indicators such as headaches, dizziness, nausea, and blurred vision often signal a concussion, while delayed signs—memory problems, mood changes, and...
GLP‑1 Weight‑Loss Drugs Spark Global Overhaul of Obesity Care
Prescriptions for GLP‑1 medicines such as Ozempic and Mounjaro have surged globally, creating supply shortages, spurring counterfeit markets, and forcing regulators from the U.S., Canada, Europe and India to tighten controls. The shift is redefining obesity as a chronic disease...
Havencrest Capital Invests in OFFOR Health, Adding to Healthcare Services Portfolio
Havencrest Capital has made a private‑equity investment in OFFOR Health, a healthcare‑services provider, as listed in a JD Supra deal tracker. The transaction, whose financial terms were not disclosed, signals the firm’s ongoing focus on expanding its health‑care portfolio.
From Symptoms to Sensors: How Technology Is Changing the Way We Detect Dehydration
Dehydration detection is moving from symptom‑based tests to continuous, sensor‑driven monitoring. Bioelectrical impedance, microfluidic sweat analysis, optical spectroscopy and AI algorithms now provide real‑time hydration metrics with accuracies above 90%. Wearable platforms are already deployed in military units, sports teams,...
Phase‑III Trial Shows Clascoterone 5% Boosts Hair Count 2.4‑Fold in Men with Androgenetic Alopecia
A Phase‑III study of clascoterone 5% topical solution demonstrated a 2.39‑fold increase in hair count after one year, positioning the acne drug as a promising therapy for androgenetic alopecia. The trial, involving 1,465 men, also confirmed a safety profile comparable...
Rubedo’s AI‑Designed Senolytic RLS‑1496 Begins First‑In‑Human Trials
Rubedo Life Sciences has started Phase 1 human trials of RLS‑1496, the first GPX4‑targeting senolytic drug designed by its ALEMBIC AI platform. The parallel trials in Europe and the United States aim to assess safety and dosing of a therapy that...
Carfentanil Seizures Jump 1,400 Times in 2025 as Traffickers Shift to Ultra‑Potent Opioid
U.S. drug labs identified carfentanil in 1,400 seizures in 2025, up from 145 in 2023, as traffickers turn to the 100‑times‑more‑potent fentanyl analog. The surge comes as overall fentanyl seizures and overdose deaths decline, prompting a $362 million DEA budget boost.
Microfluidic Lens Rivals Electronics for Glaucoma Monitoring
Can a microfluidic contact lens match electronic systems for glaucoma care while staying comfortable enough for daily wear? https://spectrum.ieee.org/smart-contact-lens-glaucoma-microfluidics?share_id=9388906
How Credentialing and Culture Impact Physician Mental Health
Physician burnout and mental‑health stigma are intensifying as 46% of health workers report frequent exhaustion, costing the U.S. health system roughly $4.6 billion a year. Credentialing forms that probe mental‑health history and drug use create a privacy fear that discourages clinicians...
Why GLP-1 Medications Require Expert Nutrition Guidance
GLP‑1 medications are reshaping obesity and diabetes treatment by delivering significant weight loss, but their appetite‑suppressing effects can lead to protein shortfalls, vitamin gaps, and muscle loss. A recent Academy of Nutrition and Dietetics survey found 98% of professionals flag...
These Alzheimer’s Drugs Were Supposed to Revolutionize the Way We Fight the Disease. The Reality Is More Complicated.
A new Cochrane Library review casts doubt on the clinical value of Leqimbi and Kisunla, the two Alzheimer’s drugs hailed as breakthroughs in recent years. The analysis of multiple trials finds the medications produce little to no improvement in cognition,...
Female Doctors Deliver Better Care, Yet Face Unrewarded Burden
Female doctors get their patients better outcomes. Female doctors do not outlive their male colleagues. The trade is not an accident. Dr. Noemi Adame, board-certified pediatrician and founder of Culver Pediatric Center, sat with this on The Podcast by KevinMD. ...
First International Consensus on How to Design, Test and Evaluate Robotic Systems for Stroke Treatment
A new position statement published in the Journal of the American Heart Association establishes the first international consensus on designing, testing, and evaluating robotic systems for mechanical thrombectomy (MT) in stroke care. The framework, created by a multidisciplinary panel of...
Lupin Receives Form 483 After USFDA Inspection of Somerset Unit
Lupin Ltd disclosed that the U.S. Food and Drug Administration issued a Form 483 after inspecting its Somerset, New Jersey manufacturing site from April 13‑17, 2026. The FDA cited three observations that may represent violations of the FD&C Act. Lupin said it will address...
8 Most Undervalued Biotech Stocks to Buy Right Now
The article spotlights eight biotech stocks deemed undervalued, selected via a Finviz screen for forward P/E below 15 and high hedge‑fund ownership as of Q4 2025. It highlights Valneva SE’s €174.7 million (≈$192 million) 2025 revenue, strong cash position of €109.7 million (≈$121 million), and...
5 Most Undervalued Biotech Stocks to Buy Right Now
ADMA Biologics (NASDAQ:ADMA) appears on a list of the five most undervalued biotech stocks, even as Cantor Fitzgerald downgraded the shares to neutral after a short‑seller report alleged channel‑stuffing and rising days‑sales‑outstanding. Cantor highlighted the lack of clear response from...
Older Australians to Receive Free RSV Vaccinations
Australia will begin offering free RSV vaccinations to seniors and Indigenous adults from May 15, as part of a $445.3 million AUD (≈$295 million USD) federal program. Eligible groups include all Australians aged 75+ and Aboriginal and Torres Strait Islander people aged 60+,...
Managing Infection Risks in BCMA Bispecific Antibody Therapy: Ajay K. Nooka, MD, MPH
The FDA granted full approval to teclistamab (Tecvayli), a BCMA bispecific antibody for relapsed/refractory multiple myeloma, despite grade 3‑4 infection rates of 50‑60 percent observed in early trials. Ajay K. Nooka, MD, MPH, explained that these infections occurred largely during the COVID‑19 pandemic...
GPT-Rosalind Lands: What OpenAI’s First Domain-Specific Life Sciences Model, the Codex Life Sciences Plugin & the Trusted Access Program Actually...
OpenAI unveiled GPT‑Rosalind on April 16, its first domain‑specific model built for life‑sciences tasks such as biochemistry, genomics, and protein engineering. Access is limited to a Trusted‑Access program that currently includes Amgen, Moderna, Thermo Fisher Scientific, the Allen Institute and...
Hospitals Must Prioritize Nutrition, Not Just Medication
When are hospitals going to realise that good nutrition will support many patients to improve their health alongside meds. The food my mum is currently being served can only be described as cold, brown sludge.
Standard-Dose Antibiotic Is the 'Preferred Choice' Of Treatment for Uncomplicated Acute Sinusitis
A nationwide retrospective study of 521,244 U.S. adults with uncomplicated acute sinusitis found that standard‑dose amoxicillin performs as well as the broader‑spectrum amoxicillin‑clavulanate. Both drugs yielded a roughly 3% treatment‑failure rate, but patients on amoxicillin‑clavulanate experienced a modestly higher incidence...
Why Current Solutions to Physician Burnout Are Failing
After a decade of wellness programs, physician burnout remains at 45% according to the AMA’s 2023 survey, essentially unchanged from earlier levels. Traditional solutions target environmental stressors—hours, bureaucracy, EHR—but the article argues this model fails because the harsh environment persists....
Study Finds Digital Tools Ease Pandemic Loneliness for Seniors
Researchers published a study analyzing how digital interventions reduced social isolation and protected mental health among older adults during the COVID‑19 pandemic. The paper highlights that technology use was linked to lower loneliness scores, underscoring the importance of digital inclusion...
Prostate Cancer: A PSA on PSA
Prostate cancer mortality is stalling as advanced‑stage diagnoses climb in the United States and Canada, a trend linked to the 2008‑2012 USPSTF move away from routine PSA screening. New evidence shows that refined PSA strategies—tracking PSA velocity and PSA density—combined...
Study at European Obesity Congress Disproves Childhood Adiposity Rebound Theory
Researchers led by Professor Andrew Agbaje presented data at the European Congress on Obesity that overturns the 42‑year‑old adiposity rebound theory. Using waist‑to‑height ratios, the study argues that rising muscle mass, not a rebound in body fat, explains BMI patterns...
WHO Launches Global Webinar to Boost Health Sector Support for Parents and Caregivers
The World Health Organization, together with the Child Health Task Force and the ECD Action Network, convened a global webinar to press health ministries to embed evidence‑based parenting support into routine services. The session highlighted practical tools and case studies...
East Anglian Air Ambulance Launches £8.2m Appeal for New Cambridge Base as Airport Closure Looms
East Anglian Air Ambulance (EAAA) has launched an $10.5 million fundraising appeal to build a new base at New Shardelowes Farm near Fulbourn, as Cambridge City Airport faces closure in 2030. The charity currently operates two hubs, and losing the Cambridge...
Emergency Room Survey Uncovers Measles Vaccine Gaps and Hesitancy Across the US
A University of California Riverside‑led study surveyed 2,459 adult patients in ten U.S. emergency departments and uncovered widespread gaps in knowledge, receipt, and acceptance of the measles‑mumps‑rubella (MMR) vaccine. The data, collected from April to December 2024, show that many...
Teva Recalls Over 300,000 Clonidine Transdermal Cartons After FDA Upgrades Recall Level
Teva Pharmaceuticals USA recalled more than 300,000 cartons of its Clonidine Transdermal System on March 19, after the FDA upgraded the recall classification because the product used an unapproved raw material. The move underscores heightened regulatory scrutiny of blood‑pressure therapies...
Viz.ai Secures Fourth Gold Edison Award for AI‑Driven Hemorrhage Care Platform
Viz.ai announced it has won a Gold Edison Award for its Viz Hemorrhage AI platform, marking the company's fourth such honor. The award recognizes the solution’s ability to detect intracranial hemorrhage in real time and coordinate care across a network...
Clinicians Unprepared for Value-Based Care System
Clinicians are failing at value-based care because no one taught them the system [PODCAST] http://dlvr.it/TS5n8W Podcast #PublicHealthPolicy
Pfizer Unveils Nanoparticle Platform to Target Tumors, Reduce Side Effects
Pfizer said today its Targeted Therapeutics Unit in Oncology R&D is advancing a nanotechnology platform that uses engineered nanoparticles to deliver drugs straight to cancer cells. The approach is designed to boost efficacy while cutting the collateral damage typical of...
FDA Approves TVTX, Philips Spectral CT, Rejects REPL; New Trials Unveiled
The U.S. Food and Drug Administration granted clearance to TVTX and Royal Philips' AI‑driven Spectral CT system, while rejecting the REPL gene‑therapy candidate. In the same week, several biotech firms disclosed fresh clinical‑trial launches and Carbios disclosed a deeper fiscal‑2025...
The New Stack CMS Built While You Weren't Looking
CMS has unveiled a coordinated payment architecture that expands beyond traditional fee‑for‑service, launching the ACCESS model with over 150 approved participants slated to begin July 5. The model pays Medicare beneficiaries directly for outcome‑aligned chronic disease management, featuring consumer brands...
Real Risks & Theoretical Benefits of Drinking Raw Milk
The blog post warns that raw milk carries significant microbiological hazards, including Salmonella, Shiga‑toxin‑producing E. coli, Campylobacter, Listeria and parasites such as Cryptosporidium. Because it spoils quickly—within hours at room temperature and even faster in heat—raw milk must be collected under...
The Help That Many Older Americans Need Most
The New York Times highlights how community health workers (CHWs) are stepping in as the U.S. faces a shortage of medical professionals and a rapidly aging population. In rural Oregon, CHW Sandy Guzman assists isolated seniors with transportation, housing navigation,...
Journalists Talk Hot Health Topics: Urgent Care Clinics Performing Abortions and Doulas’ Pay
KFF Health News featured three journalists discussing pressing health policy issues: urgent‑care clinics expanding abortion services in rural Michigan, Medicaid cuts jeopardizing doula reimbursement for Indigenous communities in Montana, and Farm Bureau health plans lowering premiums by excluding high‑risk members....
Severe Malaria May Affect Children’s Cognitive Abilities More than a Decade Later
A long‑term Ugandan cohort study of nearly 1,000 children shows that survivors of cerebral malaria or severe malarial anemia score lower on cognitive and math tests up to 15 years after infection. The deficits translate to a loss of roughly...
Lilly CEO Sees Weight-Loss Drugs Reaching About Half of Potential Users at Peak
Eli Lilly CEO David Ricks told investors that GLP‑1 weight‑loss drugs will likely reach only about half of the 500 million people worldwide who could benefit, due to institutional and cost barriers. He noted that today roughly one in ten eligible patients...
Deadly Delays and Treatment in Chains: How Prisons Are Failing Women with Cancer
A UCL study finds people diagnosed with cancer in English prisons are 28% less likely to receive curative treatment, leading to a 9% higher mortality risk. Women prisoners face compounded barriers, being up to three times less likely to receive...
DOJ Targets NewYork-Presbyterian in Steering Restrictions Antitrust Suit
The U.S. Department of Justice, together with the Southern District of New York, has filed a civil antitrust lawsuit against New York‑Presbyterian Hospital, accusing it of using contract clauses that block insurers from steering patients to lower‑cost providers. The government...
Retatrutide - Possibly Better than Semaglutide B/C Lower Nausea/Side Effect Profile, but Higher Heart Rate
Retatrutide, a triple‑agonist peptide, is generating buzz for delivering dramatic weight loss at doses of 8‑12 mg, rivaling semaglutide while causing fewer nausea complaints. Early users note that appetite suppression diminishes after several weeks, yet the drug continues to support weight‑maintenance...
Women’s Health Strategy Won’t End Medical Misogyny – but the Markets Could
The UK government unveiled a renewed Women’s Health Strategy, featuring a £1.5 million (~$1.9 million) femtech challenge fund, commitments to slash gynae waiting lists, embed menopause checks in routine NHS exams, and require sex‑based data for publicly funded research. The plan tackles...
Pfizer Vaccine Safe, Effective in Juvenile Inflammatory Disease
A multi‑center trial published this week confirms that Pfizer's mRNA COVID‑19 vaccine is both safe and effective for children suffering from juvenile inflammatory diseases such as juvenile idiopathic arthritis and inflammatory bowel disease. The study tracked 312 participants aged 5‑17,...
White House Pushes Vape Flavors; FDA Commissioner Blocks Plan
The 🇺🇸 White House is pushing to allow more vape flavors on the market for the first time in years, Food and Drug Administration Commissioner Marty Makary opposes the move and is blocking the plan - WSJ
NC's CON Laws Still Stifle Care Innovation Post-Reform
A great dive into NC's Certificate of Need laws - and how, even after 2023 reforms, the anticompetitive rules still block new medical services, discourage innovation, and screw NC patients just to line the pockets of well-connected hospital groups: https://t.co/e4QutO0UUf...
You Are in the 4%
The IRDAI annual report shows only 4% of India’s 1.4 billion population—about 60 million people—carry personal health insurance. Despite rising medical costs, crowdfunding for treatment has surged 2‑2.5 times since 2022, highlighting a financing gap. The author identifies four barriers to coverage: lack...
Trump Pushes to Loosen Restrictions on Psychedelics
Clearly, he and his cabinet are already imbibing.... Trump plans to ease access to psychedelics like psilocybin, ibogaine https://t.co/pwqU0fllVb